Axa
ARWR icon

Axa’s Arrowhead Research ARWR Stock Holding History

Axa’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,400
Closed -$1.56M – 1205
2020
Q4 		$1.56M Hold
20,400
– – ﹤0.01% 903
2020
Q3 		$878K Sell
20,400
-40,700
-67% -$1.76M ﹤0.01% 961
2020
Q2 		$2.64M Buy
61,100
+300
+0.5% +$10.6K 0.01% 765
2020
Q1 		$1.75M Sell
60,800
-18,400
-23% -$742K 0.01% 767
2019
Q4 		$5.02M Buy
79,200
+64,900
+454% +$3.22M 0.02% 617
2019
Q3 		$403K Buy
+14,300
New +$423K ﹤0.01% 1133
2019
Q2 		– Sell
-77,700
Closed -$1.43M – 1277
2019
Q1 		$1.43M Buy
77,700
+22,900
+42% +$378K 0.01% 913
2018
Q4 		$681K Buy
54,800
+19,500
+55% +$267K ﹤0.01% 1035
2018
Q3 		$677K Buy
35,300
+5,000
+17% +$82.1K ﹤0.01% 1100
2018
Q2 		$412K Buy
30,300
+9,300
+44% +$86.9K ﹤0.01% 1171
2018
Q1 		$151K Hold
21,000
– – ﹤0.01% 1334
2017
Q4 		$77K Buy
+21,000
New +$78K ﹤0.01% 1335

Other funds holding ARWR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axa's ARWR Position: Q1 2021 in Review

Axa sold out of Arrowhead Research (ARWR) in Q1 2021, closing a stake of 20,400 shares — an estimated $1.56M sold.

Axa first reported a position in ARWR in Q4 2017 and held it in 12 quarters. The position peaked at $5.02M in Q4 2019. 289 funds tracked by Wall St. Rank hold ARWR as of Q1 2021.

  • Axa reported no remaining Arrowhead Research position as of Q1 2021 after selling out during the quarter.
  • Axa sold 20,400 Arrowhead Research shares in Q1 2021, an estimated $1.56M.
  • Axa first reported a position in Arrowhead Research in Q4 2017 and held it in 12 quarters.
  • Axa's Arrowhead Research position peaked at $5.02M in Q4 2019.
  • 289 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2021.

Based on Axa's 13F filing for Q1 2021, filed 14 May 2021.